Is BIOA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BIOA. It does not provide personalized investment advice.

BIOA (BioAge Labs, Inc. Common Stock) Stock Analysis - Financials

BioAge Labs, Inc. Common Stock (BIOA) is a publicly traded Healthcare sector company. As of September 2, 2026, BIOA trades at $9.46 with a market cap of $436.02M and a P/E ratio of -4.00. BIOA moved +0.68% today. Year to date, BIOA is -25.80%; over the trailing twelve months it is +104.73%. Its 52-week range spans $2.88 to $25.96. Analyst consensus is strong buy with an average price target of $35.63. Rallies surfaces BIOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BIOA's key financials?

BIOA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BIOA recently traded at $9.46. Market cap is $436.02M. P/E ratio is -4.00. Revenue is $10.36M.

BIOA Key Metrics

Key financial metrics for BIOA
Metric	Value
Price	$9.46
Market Cap	$436.02M
P/E Ratio	-4.00
EPS	$-2.38
Dividend Yield	0.00%
52-Week High	$25.96
52-Week Low	$2.88
Volume	92.06K
Avg Volume	0
Revenue (TTM)	$10.36M
Net Income	$-94.46M
Gross Margin	0.00%

BIOA Analyst Consensus

9 analysts cover BIOA: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.63.

Common questions about BIOA

What are BIOA's key financials?: BIOA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BIOA recently traded at $9.46. Market cap is $436.02M. P/E ratio is -4.00. Revenue is $10.36M.
Is BIOA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BIOA. It does not provide personalized investment advice.